 |
인쇄하기
취소
|
Key word for drugmakers in 2012 is survival through innovation and R&D
The country’s pharmaceutical companies face tough times ahead with the government’s plan to slash drug prices starting April, heaping strain on the generic-focused Korean industry.
Currently, Korean firms remain jittery over how to sustain generic drug manufacturing.
“Given that most Korean firms rely on developing generic drugs, they would inevitably be battered by the plan if the measur...
Currently, Korean firms remain jittery over how to sustain generic drug manufacturing.
“Given that most Korean firms rely on developing generic drugs, they would inevitably be battered by the plan if the measur...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.